X @Bloomberg
Bloomberg·2025-10-24 20:12
Regulatory Approval - Bayer's menopause drug, Lynkuet, received support from US regulators [1] Market Entry - Lynkuet is expected to enter the market in November [1]
Regulatory Approval - Bayer's menopause drug, Lynkuet, received support from US regulators [1] Market Entry - Lynkuet is expected to enter the market in November [1]